Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Index
-
Market Cap
23.53M
Enterprise Value
32.64M
Income
-20.84M
Sales
0.16M
Book/sh
2.09
Cash/sh
0.19
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
2
IPO
Oct 11, 2016
P/E
-
Forward P/E
-
PEG
-
P/S
147.06
P/B
1.58
P/C
17.05
P/FCF
-
EV/EBITDA
-
EV/Sales
204.00
Quick Ratio
0.16
Current Ratio
0.16
Debt/Eq
0.10
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-4.30
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
85.07% 88.24%
Sales past 3/5Y
- -
EPS Y/Y TTM
61.09%
Sales Y/Y TTM
-
EPS Q/Q
-195.47%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
149.35% -
Insider Own
18.25%
Insider Trans
0.00%
Inst Own
8.19%
Inst Trans
-
ROA
-32.94%
ROE
-56.50%
ROIC
-111.81%
Gross Margin
-815.60%
Oper. Margin
-7655.42%
Profit Margin
-12999.98%
SMA20
-35.13%
SMA50
-22.65%
SMA200
-8.35%
Trades
Shs Outstand
6.91M
Shs Float
5.83M
52W High
6.93 -52.37%
52W Low
1.87 76.47%
Volatility
27.46% 16.17%
ATR (14)
0.74
RSI (14)
34.96
Beta
1.72
Rel Volume
0.00
Avg Volume
118.16K
Volume
0
Perf Week
-38.32%
Perf Month
-21.80%
Perf Quarter
-15.17%
Perf Half Y
-12.70%
Perf YTD
-29.18%
Perf Year
-12.47%
Perf 3Y
-79.63%
Perf 5Y
-99.99%
Perf 10Y
-100.00%
Prev Close
3.30
Price
3.30
Change %
0.00%
GridAI Technologies Corp. is a diversified technology and life sciences company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Interim CEO & DirectorMr. Jason David Sawyer
Interim Chief Financial OfficerMs. Anna Skowron
Chief Executive Officer of GridAIMr. Marshall Chapin